Table 1 Comparisons of patient characteristics and laboratory findings according to QFT-GIT results
QFT-GIT (−), n = 47, n(%) | QFT-GIT (+), n = 114, n(%) | Indeterminate, n = 2, n(%) | p value* | |
|---|---|---|---|---|
Age, median, years (IQR, range) | 51 (34, 22–83) | 55 (27.2, 18–95) | 66.5 | 0.09 |
Sex, male | 25 (53.2%) | 60 (52.6%) | 0 (0%) | 0.95 |
BMI, median, kg/m2 (IQR, range) | 22.4 (4, 16.7–26.2) | 22.1 (4.4, 19.2–25.7) | 21.3 | 0.74 |
Underlying disease | ||||
Diabetes mellitus | 3 (6.4%) | 13 (11.4%) | 1 (50.0%) | 0.33 |
Hypertension | 13 (27.7%) | 28 (25.6%) | 1 (50.0%) | 0.68 |
Malignancy | 10 (21.3%) | 22 (19.3%) | 1 (50.0%) | 0.19 |
Solid cancer | 3 | 14 | 1 | |
Hematologic | 7 | 8 | 0 | |
malignancy | ||||
Chronic kidney disease | 5 (10.6%) | 7 (6.1%) | 1 (50.0%) | 0.32 |
Autoimmune disease | 3 (6.4%) | 2 (1.8%) | 1 (50.0%) | 0.12 |
Transplant | 3 (6.4%) | 6 (5.3%) | 0 (0%) | 0.78 |
HIV infection | 0 (0%) | 1 (0.9%) | 0 (0%) | 0.52 |
Prior tuberculosis history | 2 (4.3%) | 16 (14.0%) | 0 (0%) | 0.07 |
Old fibrotic scar on chest X-ray | 1 (2.1%) | 18 (15.8%) | 0 (0%) | 0.015 |
Disseminated disease | 0 (0%) | 5 (4.4%) | 0 (0%) | 0.33 |
White blood cells, × 109/L, median (IQR, range) | 66.6 (58.6,17.1–173) | 58.2 (48.0–79.6,10.1–206.7) | 67.5 | 0.39 |
Total lymphocyte, × 109/L, median(IQR, range) | 13.8 (13.2,2.6–49.2) | 13.2 (10.2, 2.3–45.8) | 7.5 | 0.62 |
Hemoglobin,g/dl, median (IQR, range) | 11.75 (2.13, 7.4–28.20) | 12.1 (3.2, 7.2–17.10) | 8.85 | 0.36 |
ESR,mm/h, median (IQR, range) | 46.0 (60.5, 2–120) | 44.0 (54.4,3–120) | 59.5 | 0.19 |
C-reactive protein, mg/dl, median (IQR, range) | 1.87 (5.43,0.04–29.50) | 2.03 (7.8,0.03–30.8) | 1.11 | 0.79 |
Albumin, g/dl median(IQR, range) | 3.5 (1.0,2.3–4.4) | 3.5 (1.2,2.0–4.8) | 2.9 | 0.52 |